Li Liao

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Top Venues

Science advances

Cancer research

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ling Deng, Li Liao, Yin-Ling Zhang, Shao-Ying Yang, Shu-Yuan Hu, Lisa Andriani, Yun-Xiao Ling, Xiao-Yan Ma, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1. Science advances 10 (14) (2024)
Ling Deng, Li Liao, Yin-Ling Zhang, Shao-Ying Yang, Shu-Yuan Hu, Lisa Andriani, Yun-Xiao Ling, Xiao-Yan Ma, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1. Science advances 10 (14) (2024)
Ling Deng, Li Liao, Yin-Ling Zhang, Shao-Ying Yang, Shu-Yuan Hu, Lisa Andriani, Yun-Xiao Ling, Xiao-Yan Ma, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1. Science advances 10 (14) (2024)
Li Liao, Ling Deng, Yin-Ling Zhang, Shao-Ying Yang, Lisa Andriani, Shu-Yuan Hu, Fang-Lin Zhang, Zhi-Min Shao, Da-Qiang Li
C9orf142 transcriptionally activates MTBP to drive progression and resistance to CDK4/6 inhibitor in triple-negative breast cancer. Clinical and translational medicine 13 (11) (2023)
Li Liao, Yin-Ling Zhang, Ling Deng, Chao Chen, Xiao-Yan Ma, Lisa Andriani, Shao-Ying Yang, Shu-Yuan Hu, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
Protein phosphatase 1 subunit PPP1R14B stabilizes STMN1 to promote progression and paclitaxel resistance in triple-negative breast cancer. Cancer research (2022)